[Protontherapy: basis, indications and new technologies].

Abstract:

:With over 70,000 patients treated worldwide, protontherapy has an evolution on their clinical applications and technological developments. The ballistic advantage of the Bragg peak gives the possibility of getting a high conformation of the dose distribution to the target volume. Protontherapy has accumulated a considerable experience in the management of selected rare malignancies such as uveal melanomas and base of the skull chordomas and chondrosarcomas. The growing interest for exploring new and more common conditions, such as prostate, lung, liver, ENT, breast carcinomas, as well as the implementation of large pediatric programs advocated by many experts has been challenged up to now by the limited access to operational proton facilities, and by the relatively slow pace of technical developments in terms of ion production, beam shaping and modelling, on-line verification etc. One challenge today is to deliver dynamic techniques with intensity modulation in clinical facilities as a standard treatment. We concentrate in this paper on the evolution of clinical indications as well as the potentialities of new technological concepts on ion production, such as dielectric walls and laser-plasma interactions. While these concepts could sooner or later translate into prototypes of highly compact equipments that would make easier the implantation of cost-effective hospital-based facilities, the feasibility of their clinical use must still be proved.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Mazal A,Habrand JL,Delacroix S,Datchary J,Dendale R,Desjardins L,Ferrand R,Malka V,Fourquet A

doi

10.1684/bdc.2010.1149

subject

Has Abstract

pub_date

2010-07-01 00:00:00

pages

831-46

issue

7

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(15)30813-4

journal_volume

97

pub_type

杂志文章
  • [Prevalence of cancer, health care and daily life assistance in people aged 75 or over living in the Tarn area (France)].

    abstract::The association between cancer and dependence was estimated using a cross-sectional study among persons 75 years of age or-older in Tarn county (area with a cancer registry recognized by the National Committee of Registries). A representative random sample stratified on age, sex, and size of district, was drawn using ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Faliu B,Berthier F,Grosclaude P,Aptel I,Cayla F,Machelard-Roumagnac M,Duchene Y

    更新日期:1997-02-01 00:00:00

  • [Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view].

    abstract::Targeted therapy against the EGF receptor was shown to be effective in a subgroup of patients with KRAS wild-type colorectal cancer. Therefore, cetuximab (Erbitux) or panitumumab (Vectibix) obtained the authorization by the EMEA restricted to patients with KRAS wild-type tumours. KRAS mutational testing has become par...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0996

    authors: Blons H,Laurent-Puig P

    更新日期:2009-12-01 00:00:00

  • [Recent data on the immunology of tumors. Mechanisms of escape of immunological control. Role of suppressor cells].

    abstract::Cells in spleens from tumor bearing animals were found to inhibit in vitro reactivity of lymphocytes to a variety of stimulants. These suppressor cells inhibited the stimulation of normal lymphocytes by mitogens : P.H.A.-Con A-L.P.S. They were adherent cells, bore immunoglobulins at their surface and did not bear the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lespinats G,Poupon MF

    更新日期:1976-04-01 00:00:00

  • [Hypercalcemia a sign of medullar transformation of low grade malignant lymphoma. Apropos of a case].

    abstract::The authors report a case of transformation of a low grade non-Hodgkin's lymphoma (LGL) to an agressive lymphoma in a 55 year-old woman who was treated by fludarabine phosphate. The only sign of transformation was the supervention of an hypercalcemia. This complication is rare in the evolution of the LGL and the mecha...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Joly F,Reman O,Penther D,Levaltier X,Troussard X,Leporrier M

    更新日期:1996-02-01 00:00:00

  • [Management of analgesics in cancer patients with renal impairment].

    abstract::Pain is frequent in cancer patients. To date, there is a consequent therapeutic arsenal so to manage pain; the different treatment strategies are the subject of various recommendations. Patients with cancer also frequently suffer from renal insufficiency, and this comorbidity may disrupt or jeopardize the analgesic st...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1488

    authors: Rey JB,Tran T,Ammar D,Parent D,Janus N,Launay-Vacher V

    更新日期:2012-03-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [Better screening for work-related cancers: The experience of Brest University Hospital Occupational Disease Center inpatient service].

    abstract:INTRODUCTION:An in-patient clinical service has been set up in March 2016 in the Occupational Diseases Center of Brest University Hospital, France, to seek for work-relatedness of diseases in patients hospitalized into the oncology and hematology departments. We present here data after two years of existence. METHODS:...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.01.013

    authors: Grignoux J,Loddé B,Dewitte JD,Larabi L,Durand-Moreau Q

    更新日期:2020-04-01 00:00:00

  • [Respiratory sequellae after alternated chemotherapy and radiotherapy for small cell anaplastic cancer].

    abstract::The authors analyze the respiratory sequelae in 19 patients with limited small cell lung carcinoma who survived for more than 30 months following an alternating chemo-radiotherapeutic combined regimen. The clinical tolerance measured with respiratory functional test is acceptable. In two patients an effort dyspnea is ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: de Cremoux H,Baldeyrou P,Martin M,Ruffié P,Arriagada R,Le Chevalier T

    更新日期:1987-01-01 00:00:00

  • [Rare cancers and new radiotherapy techniques].

    abstract::Rare cancers represent about a quarter of all cancers diagnosed in Europe, and their incidence is increasing. Meanwhile, scientific advances provide techniques, which become more and more sophisticated in the domain of radiotherapy. Treatment options for radiotherapy rare cancers are increasing, but are not yet evalua...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.12.001

    authors: Espenel S,Trone JC,Vallard A,Guy JB,Moriceau G,Méry B,Langrand-Escure J,Rivoirard R,de Laroche G,Chargari C,Magné N

    更新日期:2015-01-01 00:00:00

  • [Cyclooxygenase 2 inhibitors and cancer chemoprevention].

    abstract::Chemoprevention is the use of natural or synthetic compounds in order to reverse, suppress or prevent the carcinogenic process. Among the many pathways dysregulated during the carcinogenic process, cyclooxygenase-2 (Cox2) seems to be one of the most promising pathways to target in order to achieve chemopreventive and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Masmoudi A,Chevalier TL,Sabatier L,Soria JC

    更新日期:2004-05-01 00:00:00

  • [The Stockholm preoperative radiotherapy of operable breast cancer. Preliminary report].

    abstract::The 4 year results of a prospective clinical trial on the treatment of operable breast cancer, comparing the effects of preoperative radiotherapy followed by surgery with those of surgery followed or not by postoperative radiotherapy are presented for patient groups of approximately 100 each. At 4 years 85 per cent su...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Wallgren A,de Schryver A,Wasserman J

    更新日期:1977-01-01 00:00:00

  • [Metastasis to unusual sites].

    abstract::Metastases are responsible for the majority of deaths from solid cancers. Metastatic phenomenon, complex, is a multi-step process where interactions between cells and with the microenvironment are essential. The organ tropism, that is the propensity of a cancer to metastasize to specific organs, can be explained by se...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1889

    authors: Olivier T,Gastaud L,Maschi C,Caujolle JP,Cupissol D,Thariat J

    更新日期:2014-02-01 00:00:00

  • [Breast cancer screening: On our way to the future].

    abstract::Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important improvements in prognosis over the past 20 years, breast cancer scree...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.06.005

    authors: Delaloge S,Bachelot T,Bidard FC,Espie M,Brain E,Bonnefoi H,Gligorov J,Dalenc F,Hardy-Bessard AC,Azria D,Jacquin JP,Lemonnier J,Jacot W,Goncalves A,Coutant C,Ganem G,Petit T,Penault-Llorca F,Debled M,Campone M,Levy

    更新日期:2016-09-01 00:00:00

  • [Sarcomas of soft tissue in the adult. Therapeutical indications].

    abstract::Treatment of soft-tissue sarcomas has to deal simultaneously with three goals: 1) to obtain the control of the primary tumor, 2) to preserve the function, and 3) to treat the micrometastatic disease. For local control, surgery remains the most efficient treatment, but the extent of the resection of macroscopically non...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bui NB

    更新日期:1988-01-01 00:00:00

  • [Frequency of cancer in France: 2004 update].

    abstract::The most recent cancer mortality and morbidity data available for France are presented. In 1999, cancers are the first cause of death among men (87,000 deaths) and the second most common among women (57,000 deaths) after cardiovascular diseases. Lung cancer is the most common cause of cancer death (21,000) in the male...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill C,Doyon F

    更新日期:2004-01-01 00:00:00

  • [Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma].

    abstract::Important improvements in local control with increasing function-sparing treatment have been achieved in adult soft tissue sarcomas (STS). However, the global prognosis of these diseases remains poor and 40% of patients with STS currently die of metastases within 5 years. In fact, the impact of chemotherapy remains de...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Debled M,Ravaud A,Stöckle E,Nguyen BB

    更新日期:1997-06-01 00:00:00

  • [Natural history of the cervical precancerous lesions (author's transl)].

    abstract::The histogenesis of precancerous lesions and of carcinoma in situ has undergone deep changes over the past ten years. In particular, concepts of re-epidermisation by indirect metaplasia has made it possible to understand the progressive process which results what are generally described as dysplasias. These lesions we...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: de Brux J

    更新日期:1979-01-01 00:00:00

  • An ethics dilemma: when parents and doctors disagree on the best treatment for the child.

    abstract::The increasing complexity of present day medicine--with highly effective and yet risky treatments, individual and collective expectations, and evolving ideological and cultural landmarks--often gives rise to difficult ethical problems. Specific meetings are valuable for understanding such problems, acquiring the relev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Oppenheim D,Brugières L,Corradini N,Vivant F,Hartmann O

    更新日期:2004-09-01 00:00:00

  • [Li-Fraumeni syndrome].

    abstract::The Li-Fraumeni syndrome is an autosomal dominant syndrome representing a genetic predisposition to a wide spectrum of tumours including sarcomas, breast carcinomas, brain tumors and adrenocortical carcinomas. In most of the cases, tumours will develop in children and young adults. Germline mutations of the tumor supp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frebourg T

    更新日期:1997-07-01 00:00:00

  • [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].

    abstract::The authors present 143 cases of breast carcinoma T1 and T2, N0, N1, N2 and N3 without clinical signs of bone metastasis. They study the value of bone scintigraphy with technetium 99m labelled diphosphonates. One hundred and twelve patients had normal bone scans; 31 patiets showed abnormal fixation sites: in 23 (16%) ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Stines J,Stalars J,Dartois D,Chardot C

    更新日期:1980-01-01 00:00:00

  • [Present clinical status of hyperthermia associated with radiotherapy (author's transl)].

    abstract::Improved techniques for inducing heat: ultrasound, microwaves, diathermy with different application modalities, capable of producing localized superficial or deep, regional or total body hyperthermia have been responsible for the multiplication of clinical trials. These studies have confirmed the tumoricidal effect of...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Jaulerry C,Bataini JP,Brunin F,Gaboriaud G

    更新日期:1981-01-01 00:00:00

  • [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].

    abstract::In our hospital, most of the patients with a cancer received palliative chemotherapy. Then, we wanted to know in which conditions these therapies were realised and most specially for patients with lung cancer. We noted the stage of the disease at the diagnosis, the median survival duration after diagnosis and the medi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Demange C,Thiébaux I

    更新日期:2003-03-01 00:00:00

  • [Analysis of the growth kinetics of autochthonous DMBA-induced tumors in mice of various ages and sex].

    abstract::In order to understand the kinetics of this experimental model, we studied the influence of age and sex on primary tumoral and pulmonary metastatic yields and on the growth kinetics parameters. Connective tissue tumors were induced by DMBA in male and female Swiss mice of various ages (pre and postpubertal, adult and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vrignaud P,Denechaud M

    更新日期:1985-01-01 00:00:00

  • [Low rectal cancer: conservative approach integrating radiotherapy].

    abstract::During the past two decades, the general acceptance of the surgical conservative treatments in tumors such as breast cancer, bone and soft tissue sarcoma, represents one of the significant steps achieved in the treatment of solid tumors. For low rectal cancer, abdominoperineal resection is considered the standard trea...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Allal AS

    更新日期:1996-03-01 00:00:00

  • [Epidemiology of HIV-associated malignancies].

    abstract::Human immunodeficiency virus (HIV)-associated malignancies include acquired immunodeficiency virus: Aids-defining malignancies, Kaposi's sarcoma, (KS), non-Hodgkin's lymphoma (NHL), and, since 1993, invasive cervical cancer (1CC), and non-Aids defining malignancies. Most cancers that are associated with HIV infection ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Launay O,Guillevin L

    更新日期:2003-05-01 00:00:00

  • [Biology of small-cell bronchogenic carcinoma: recent advances].

    abstract::In the last ten years considerable progress has been made in small-cell lung carcinoma (SCLC) biology, along with the technical progress made in molecular biology. This progress now allows us to propose a model for the genesis and the development of this type of tumor. Tobacco, the principal causal factor plays a dual...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Levy R,Andrieu JM,Even P

    更新日期:1992-01-01 00:00:00

  • [Breast cancer's impact on work life. Survey among women of the ELIPPSE cohort].

    abstract::Working people who are diagnosed with cancer must generally stop working, and returning to work after treatment is a very important issue for them. This article investigates the impact of cancer on professional trajectory among working women after a breast cancer diagnosis. We conducted in-depth interviews with 21 wom...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1611

    authors: Gallardo L,Rey D,Peretti-Watel P

    更新日期:2012-07-01 00:00:00

  • [Sentinel node biopsy in breast cancer].

    abstract::As compared to conventional axillary dissection, the sentinel node technique is accompanied by reduced morbidity and shorter hospital stay. Based on available data, the use of this technique does not seem to yield higher rates of axillary recurrence. A combination of both radioisotope detection and blue dye increases ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0879

    authors: Hindié E,Groheux D,Espie M,Bourstyn E,Toubert ME,Sarandi F,de Roquancourt A,Giacchetti S,Cuvier C,Cahen-Doidy L,Teyton P,Misset JL,Maylin C,Moretti JL

    更新日期:2009-06-01 00:00:00

  • [Preclinical evaluation of anticancer drugs: a model remaining a model!].

    abstract::Two criteria are firstly used in the selection of new anticancer agents:--originality of the mechanism of action and significant experimental antitumor activity in an in vivo animal model. Murine tumors grafted in syngenic mice and human tumor xenografts implanted in nude mice are old models which continue to be widel...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lavelle F

    更新日期:1998-10-01 00:00:00

  • [Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example].

    abstract::Paclitaxel is often used as an adjuvant antineoplastic agent. However, very little data is available in literature on its potential genotoxicity on healthy human cells. Our objective is to study the potential in vitro genotoxicity of paclitaxel, by using the cytokinesis-blocked micronucleus assay in combination with f...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Digue L,Orsière T,Baciuchka-Palmaro M,Duffaud F,Pompili J,Favre R,Botta A

    更新日期:2002-10-01 00:00:00